NYSE · LLY
Eli Lilly and Company
$1,423.79+$50.09 (+3.65%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 1.79% below the high.
Loading market information…
TSX · CHLT.TO · CAD
Stock price, earnings
Quote as of Oct 30, 2026, 04:58 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Custom Health Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.82% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Custom Health Holdings Inc.’s next earnings report is currently expected on Dec 2, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Custom Health Holdings Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Custom Health Holdings Inc., an AI-enabled healthcare technology company that operates an infrastructure platform designed to ensure medication therapy works as intended. The company connects in-home technology, pharmacy, and pharmacist-led clinicians to create continuous visibility into a patient's therapy. Its AdhereNet platform operates an integrated pharmacy network across Canada and the U.S. supporting medication delivery, continuous monitoring, and clinical action to enable earlier engagement and support improved outcomes. The company serves payors, health systems, physician practices, community pharmacies, and primary care providers. Custom Health Holdings Inc. was formerly known as Queue Ventures Ltd. and changed its name to Custom Health Holdings Inc. in June 2026. The company was founded in 2021 and is headquartered in Brentwood, Tennessee.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$1,423.79+$50.09 (+3.65%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 1.79% below the high.
$275.60+$0.40 (+0.15%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.27% below the high.
$295.97+$5.18 (+1.78%)
AbbVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.93% below the high.
$149.58+$3.25 (+2.22%)
Merck & Co., Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.68% below the high.
$406.36-$4.55 (-1.11%)
UnitedHealth Group Incorporated’s quoted price sits in the upper half of its reported 52-week range, 11.97% below the high.
$698.48-$10.70 (-1.51%)
Thermo Fisher Scientific Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.88% below the high.
$470.90+$10.17 (+2.21%)
Amgen Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.01% below the high.
$171.95+$6.34 (+3.83%)
Gilead Sciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.05% below the high.
